Oculo-cerebro-renal Lowe syndrome: Clinical, biochemical and molecular studies in a Moroccan patient;Syndrome oculo-cérébro-rénal de Lowe: Étude clinique, biochimique et moléculaire chez un patient Marocain

Annales de Biologie Clinique

Volumn 64, Issue 1, 2006, Pages 53-59

  Chabaa L ^a   Monnier, N ^b   Dahri, S ^a   Jorio, M ^a   Lunardi, J ^b   Chabraoui, L ^a  

^a Hopital d'Enfants   (Morocco)

^b CENTRE HOSPITALIER   (France)

Author keywords

Inositol 4,5 biphosphate 5 phosphatase; Lowe syndrome; Mutation; OCRL1

Indexed keywords

EID: 32044468692     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lowe C, Terrey M, MacLachan E. Organic aciduria, decreased renal ammonia production, hydrophtalmos and mental retardation : a clinical entity. Am J Dis Child 1952 ; 83 : 164-84.
2. Kraffczyk F, Helger R, Lang H, Bremer HJ. Thin layer chromatographic screening test for aminoacid anomalies without desalting using internal standards. Clin Chim Acta 1971 ; 35 : 345-51.
3. Xiao W, Oefner PJ. Denaturating high-performance liquid chromatography : a review. Hum Mutat 2001 ; 17 : 439-74.
4. Broyer M. Tubulopathies congénitales. Paris : Elsevier, Encycl Méd Chir, 1996, Pédiatrie ; 4-084-A-10, Néphrologie- urologie, 18-064-J-10.
5. Lachaux A, David L, Descos B, Scherrer M, Hermier M. Le syndrome oculo-cérébro-rénal chez une fille, réé valuation clinique, génétique et biologique à l'âge de 10 ans. Arch Fr Pediatr 1986 ; 43 : 67-70.
6. Betend B, Scherrer M, Evrard A, Votan-Bonnamour B, Hermier M. Syndrome oculo-cérébro-rénal chez une fille. Discussion du mode de transmission génétique. Arch Fr Pediatr 1978 ; 35 : 269-79.
7. Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA. Clinical and laboratory findings in the oculo-cerebro-renal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 1991 ; 324 : 1318-25.
8. Abbassi V, Lowe CU, Calcagno PL. Oculo-cerebro-renal syndrome : a review. Am J Dis Child 1968 ; 115 : 145-68.
9. e édition. Paris : Flammarion Médecine Science, 1998 : 758.
10. Gropman A, Levin S, Yao L, et al. Unusual renal features of Lowe syndrome in a mildly affected boy. Am J Med Genet 2000 ; 95 : 461-6.
11. Zhang X, Jefferson AB, Auethavekiat V, Majerus PW. The protein deficient in Lowe syndrome is a phosphatidylinositol 4,5-biphosphate 5-phosphatase. Proc Natl Acad Sci USA 1995 ; 92 : 4853-6.
12. Lin T, Orrison B, Leahey AM, et al. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am J Hum Genet 1997 ; 60 : 1384-8.
13. Silver DN, Lewis RA, Nussbaum RL. Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms. J Clin Invest 1987 ; 79 : 282-5.
14. Tsuru T, Yamagata T, Momoi MY, Okabe I. Prenatal diagnosis of Lowe syndrome by OCRL1 messenger RNA analysis. Prenat Diagn 1999 ; 19 : 269-70.
15. Nussbaum RL, Orrison BM, Janne PA, Charnas L, Chinault AC. Physical mapping and genomic structure of the Lowe syndrome gene OCRL1. Hum Genet 1997 ; 99 : 145-50.
16. Attree O, Olivos IM, Okabe I, et al. The Lowe oculocerebrorenal syndrome gene encodes a novel protein highly homologous to inositol polyphosphate 5-phosphatase. Nature 1992 ; 358 : 239-42.
17. Suchy SF, Olivos-Glander IM, Nussbaum RL. Lowe syndrome, a deficiency of a phosphatidylinositol 4,5-biphosphate 5 phosphatase in the golgi apparatus. Hum Mol Genet 1995 ; 4 : 2245-50.
18. Zhang X, Hartz PA, Philip E, Racusen LC, Majerus PW. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5- phosphatase and accumulate phosphatidylinositol 4,5-biphosphate. J Biol Chem 1998 ; 273 : 1574-82.
19. Dressman MA, Olivos-Glander IM, Nussbaum RL, Suchy SF. OCRL1, a PtdIns (4,5)P(2) 5-phosphatase, is localized to the trans-golgi network of fibroblasts and epithelial cells. J Histochem Cytochem 2000 ; 48 : 179-89.
20. Satre V, Monnier N, Berthoin F, et al. Characterisation of a germline mosaicism in families with Lowe syndrome and identification of seven novel mutations in the OCRL1 gene. Am J Hum Genet 1999 ; 65 : 68-76.
21. Lin T, Orrison BM, Suchy SF, Lewis RA, Nussbaum RL. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients. Mol Genet Metab 1998 ; 64 : 58-61.
22. Monnier N, Satre V, Lerouge E, Berthoin F, Lunardi J. OCRL1 mutation analysis in french Lowe syndrome patients : implications for molecular diagnosis strategy and genetic counseling. Hum Mut 2000 ; 16 : 157-65.
23. Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum Mol Genet 2003 ; 12 : 2449-56.
24. Kawano T, Indo Y, Nakazato H, Shimadzu M, Matsuda I. Oculocerebrorenal syndrome of Lowe : three mutations in the OCRL1 gene derived from three patients with different phenotypes. Am J Med Genet 1998 ; 77 : 348-55.
25. Ungewickell AJ, Majerus PW. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc Natl Acad Sci USA 1999 ; 96 : 13342-4.